Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.67 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.67 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.67 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.67 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.67 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.67 |
| ▸ | HTR2A | P28223 | 1/20 | 0.67 |
| ▸ | HTR2C | P28335 | 1/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | HRH1 | P35367 | 1/20 | 0.67 |
| ▸ | DRD3 | P35462 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25293243 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25286597 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25292005 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25295583 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25286591 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25293689 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25292674 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25295689 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25294227 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL25292827 | 0.97 | GRIK1 (0.68) | CA2MAPK1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1046 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108309866-B | Adult shower gel containing licorice extract | 内蒙古伊草恋生物科技有限责任公司 | 2022-02-11 | — | — | CN | claimed |
| EP-3178807-B1 | CATIONIC LIPID | TAKEDA PHARMACEUTICALS CO (JP) | 2020-04-29 | — | — | EP | claimed |
| JP-4272052-B2 | — | — | 2009-06-03 | — | — | JP | claimed |
| EP-1419129-B1 | USE OF BRANCHED-CHAIN FATTY ACIDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN | DPHARM LTD (IL) | 2008-12-03 | — | — | EP | claimed |
| EP-1419129-A4 | USE OF BRANCHED-CHAIN FATTY ACIDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN | DPHARM LTD (IL) | 2006-05-10 | — | — | EP | claimed |
| JP-2005500305-A | — | — | 2005-01-06 | — | — | JP | claimed |
| EP-1419129-A2 | USE OF BRANCHED-CHAIN FATTY ACIDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN | D-Pharm Limited (IL) | 2004-05-19 | — | — | EP | claimed |
| US-6518311-B2 | Analgesics | D-PHARM LTD. (IL) | 2003-02-11 | — | — | US | claimed |
| WO-2003000173-A2 | USE OF BRANCHED-CHAIN FATTY ACIDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN | D-PHARM LIMITED (IL) | 2003-01-03 | — | — | WO | claimed |
| US-20020042445-A1 | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | D-PHARM LTD. (IL) | 2002-04-11 | — | — | US | claimed |
| US-5736503-A | High sudsing detergent compositions with specially selected soaps | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-07 | — | — | US | claimed |
| EP-0670885-B1 | HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS | PROCTER & GAMBLE (US) | 1997-08-20 | — | — | EP | claimed |
| US-5489393-A | NONIONIC SURFACTANT OF REDUCING SUGAR; DISHWASHING AND FABRIC LAUNDERING; ANTISOILANTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-06 | — | — | US | claimed |
| WO-1995007337-A1 | HIGH SUDSING DETERGENT WITH N-ALKOXY POLYHYDROXY FATTY ACID AMIDE AND SECONDARY CARBOXYLATE SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-16 | — | — | WO | claimed |
| WO-1994012608-A1 | HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS | THE PROCTER & GAMBLE COMPANY (US) | 1994-06-09 | — | — | WO | claimed |
| EP-0249075-B1 | AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS | AMERICAN CYANAMID COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| EP-4737504-A2 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| EP-4276090-B1 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND PREPARATION AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-04-29 | — | — | EP | disclosed |
| WO-1994012608-A1 | HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS | THE PROCTER & GAMBLE COMPANY (US) | 1994-06-09 | — | — | WO | disclosed |
| WO-1994000124-A1 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF | WEBER ECKARD (US) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042445-A1 | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | OPRL1, ELOVL5, ELOVL1 | CA2 1189/4885MAPK1 2955/4885GRIK1 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.